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Abstract Infection of Escherichia coli by filamentous phage fd
is mediated by the phage gene 3 protein (g3p). The g3p consists
of three domains (g3p-D1, D2 and D3) linked by flexible glycine-
rich linkers. All three domains are indispensable for phage
infectivity; the g3p-D1 domain binds to the TolA receptor
presumably at the inner face of the outer membrane, the g3p-D2
domain to the F-pilus and the g3p-D3 domain anchors g3p to the
phage coat. The N-terminal domains g3p-D1 and D2 interact
with each other; this interaction is abrogated by binding of g3p-
D2 to the F-pilus leading to the release of g3p-D1 to bind to
TolA. Here, using phages with deletions in g3p, we have
discovered a specific interaction between the two N-terminal
domains and g3p-D3, the C-terminal domain of g3p. We propose
that these interdomain interactions within g3p lead to a compact
and stable organisation when displayed on the phage tip, but that
during infection, this compact state must be unraveled.
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1. Introduction
Infection of Escherichia coli by ¢lamentous phage fd is
mediated by the phage gene 3 protein (g3p) [1,2]. The g3p
protein consists of three domains (g3p-D1, D2 and D3) con-
nected by glycine-rich linkers [3], and in which the C-terminal
domain g3p-D3 is anchored in the phage coat at the tip of the
phage [1]. The presence of all three domains is essential for
phage infectivity [1]. The central g3p-D2 domain is responsi-
ble for the adsorption of phage to the F-pilus of male E. coli,
and after penetration of the bacterial outer membrane, the
N-terminal g3p-D1 domain binds to TolA [2]. The N-terminal
domains g3p-D1 and D2 interact with each other; indeed, it
has been shown that the TolA-binding site on g3p-D1 is
blocked through a speci¢c interaction with g3p-D2 and that
the blockage is only released after interaction of g3p-D2 with
the F-pilus [2]. Whether g3p-D3 plays a role in the infection
process is not known.
The fusion of peptides or proteins to the N-terminus of
intact g3p (g3p-D123) does not compromise the infectivity
of the phage [4]. By contrast, the insertion of polypeptides
between g3p-D12 and g3p-D3 appears to reduce the infectiv-
ity of the phage about 100-fold [5]. Furthermore, if the cova-
lent link between the g3p-D12 and g3p-D3 domains is broken
and replaced by non-covalent interactions between peptides or
proteins fused to each domain, the infectivity of the phage is
reduced about 104^106-fold compared to wild-type [6^8]. This
suggests that bringing g3p-D12 and g3p-D3 together is neces-
sary but not su⁄cient to restore the infectivity of the phage.
We wondered whether the mechanism of infectivity of phage
fd required further and speci¢c interactions between g3p-D12
and g3p-D3.
2. Materials and methods
2.1. Phages and vectors
Wild-type phage fd-TET [9] contains the entire g3p protein (D123).
The g3p deletion phages, fd-D13, fd-D23 and fd-D3 were derived
from fd-TET and have been described previously [2]. Phage fd-D3*
contains (in place of the wild-type g3p) the g3p signal peptide directly
fused to residue 199 of g3p and displays therefore only the 20 C-
terminal residues of g3p-D2, the glycine-rich linker between g3p-D2
and D3 and g3p-D3 [8]. Phages fd-receptor-D3 [8] encode either the
minichaperone GroEL* (residues 191^345 of GroEL [10]) or the Jun
leucine zipper (46 residues) fused to the g3p-D3 domain (residues 199^
406). Expression and phage display of GroEL*, both as a fusion to
the N-terminus of the entire g3p (D123) or to D3 domain alone, were
veri¢ed by enzyme-linked immunosorbent assay (ELISA) using rabbit
anti-GroEL (Sigma) and anti-M13 horseradish peroxidase-conjugated
(Pharmacia) antibodies (not shown). Phage-displayed GroEL* was
e¡ective in refolding denatured human cyclophilin (not shown). The
co-selection construct fd-D12-ligand/receptor-D3 [8] encodes both an
N-terminal fusion of GroEL* (or the Jun leucine zipper) to residues
253^406 of g3p and a C-terminal fusion of the P1, P2, P3 (or the Jun
leucine zipper) peptide sequences to soluble D12 (residues 1^261 of
mature g3p). To prevent recombination within repetitive sequences
between D2 and D3 of g3p, and consequently the selection of recom-
bined phage, we inserted the kanamycin resistance (kanR, Fig. 1) gene
between the two sections of the gene 3 and removed all but 27 bp of
the repetitive sequences between g3p-D2 and D3; growth in the pres-
ence of kan completely prevented selection of phage with recombined
wild-type gene 3 [8]. Peptide P1 (GSGSGLVPRGS) corresponds to the
N-terminal peptide tag, plus a 4 amino acid spacer (italic characters),
bound to the polypeptide-binding site in the crystal structure of
GroEL minichaperone [11]. Peptide P2 (LRIQHFRVALIPF-
FAAFSLPVFG) constitutes the 23 N-terminal amino acid residues
of the L-lactamase precursor recognised by GroEL [12]. A third
‘non-substrate’ peptide, P3 (GSGSDYKDDDDK), encodes 4 amino
acid spacer (italic characters) and the Flag sequence, which is not
expected to be bound by GroEL* because of its highly negatively
charge [13]. The vector pUC119-D12-ligand [8] was used to express
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target peptides P1, P2 and P3 fusions to g3p-D12 (residues 1^261 of
mature g3p) in the E. coli periplasmic space using the g3p signal
sequence and the inducible lac promoter/operator. Standard protocols
were used to amplify by PCR and clone the DNA fragments encoding
minichaperone GroEL* and the leucine zippers from the Jun and Fos
genes [14]. Peptides P1, P2 and P3 were cloned using synthetic oligo-
nucleotide cassettes. All constructs were veri¢ed by DNA sequencing.
2.2. ELISA
Soluble g3p-D12 protein was expressed and puri¢ed from the E.
coli periplasm using an engineered C-terminal His tag as described [2].
Protein concentration was determined by absorbance at 276 nm using
a theoretical coe⁄cient extinction of 41 900 M31 cm31 [15]. Puri¢ed
g3p-D12 (15 Wg/ml in phosphate-bu¡ered saline (PBS): 25 mM
NaH2PO4, 125 mM NaCl, pH 7.0) was coated at 4‡C overnight
onto plastic microtitre plates (Maxisorb, Nunc). Plates were blocked
for 2 h at 37‡C with 2% Marvel in PBS. Polyethylene glycol (PEG)-
puri¢ed phages (see Fig. 1), normalised according to their DNA con-
tent [2], were bound in 2% Marvel in PBS at 37‡C for 1 h and detected
with horseradish peroxidase-conjugated anti-M13 antiserum (Pharma-
cia) as described [2]. Non-speci¢c binding of phages was successfully
quenched by the addition of 2% Marvel as no binding to bovine
serum albumin was observed (not shown).
2.3. In vitro restoration of phage infectivity
Di¡erent amounts of puri¢ed g3p-D12 protein were incubated over-
night at room temperature with PEG-puri¢ed phage fd-D3 corre-
sponding to 100 ng of phage DNA. The mixtures were used to infect
1 ml pilus bearing E. coli TG1 [16] cells in early log phase (OD600 nm
of about 0.6). Serial dilutions were plated onto TYE agarose supple-
mented with 15 Wg/ml tetracycline (tet) and resistant colonies (colony-
forming units (cfu)) were counted after incubation at 37‡C. The ex-
periment was performed in duplicate. For in vitro reconstitution of fd-
GroEL*-D3 infectivity, PEG-puri¢ed phages fd-GroEL*-D3 (corre-
sponding to 100 ng of phage DNA) were incubated overnight at
room temperature with serial dilutions in PBS of periplasmic extracts
containing g3p-D12-P1, g3p-D12-P2, g3p-D12-P3 or g3p-D12. Peri-
plasmic extracts were prepared from isopropyl-L-D-thiogalactoside-in-
duced TG1 E. coli cells as described [2] and normalised to the same
total protein concentration as determined by a colourimetric quanti-
¢cation assay (Bio-Rad). Expression of the three g3p-D12-peptide
fusions was about 2-fold lower than that of g3p-D12 alone as judged
by sodium dodecyl sulfate polyacrylamide gel electrophoresis and
Western blotting using anti-g3p rabbit polyclonal antibodies (kindly
provided by the late Prof. I. Rasched) followed by anti-M13 horse-
radish peroxidase conjugate antibodies (Pharmacia) (not shown). The
mixtures were used to infect TG1 cells and the infection events (cfu)
were determined. The experiment was performed in duplicate.
2.4. In vivo reconstitution of phage infectivity
For in vivo reconstitution of fd-GroEL*-D3 infectivity, 3U108
washed donor cells producing fd-GroEL*-D3 and di¡erent or no
g3p-D12 fusions were mixed with 1.5U108 washed acceptor cells (E.
coli TG1 carrying pACYC184camR ; [8]) in 1 ml 2UTY medium.
After 30 min at 37‡C, the mixed cultures were spread onto TYE
agarose containing 30 Wg/ml chloramphenicol (cam), 15 Wg/ml tet
and 25 Wg/ml kan. Infection events (cfu) were inferred from the col-
onies counted after incubation overnight at 37‡C. After selection,
typically 2U103 colonies were rescued from a 1 ml experiment. Three
independent experiments were performed and averaged.
3. Results and discussion
3.1. Speci¢c interaction between g3p-D12 and g3p-D3
We ¢rst investigated the binding of phage with di¡erent g3p
deletion mutations (Fig. 1) to g3p-D12 in ELISA (Fig. 2A).
Puri¢ed g3p-D12 was coated onto immunoassay plates and
binding of the phages fd-D13, fd-D23 or fd-D3, which lack
one or two of the N-terminal g3p domains, was compared to
that of ‘wild-type’ fd-D123 (fd-TET). Phage fd-D3, in which
neither D1 nor D2 are present, bound g3p-D12 best, followed
by fd-D13 and fd-D23, while fd-D123 bound only weakly
(Fig. 2A). These results indicate that, despite the presence of
a long, £exible glycine-rich linker between them, there is a
speci¢c interaction between the two N-terminal domains
g3p-D12 and g3p-D3. This interaction was inhibited to vary-
ing degrees by the fusion of a peptide at the N-terminus of
g3p-D3 (Fig. 2B).
3.2. Functional signi¢cance of the g3p-D12/g3p-D3 interaction
Furthermore, we found that soluble g3p-D12 protein was
able to restore (partially) the infectivity of fd-D3 phage, which
increases with the concentration of extraneous g3p-D12 up to
about 1.4 WM of g3p-D12 (Fig. 3). Higher g3p-D12 concen-
trations inhibit infection by phage fd-D3 (Fig. 3) presumably
by competing with the phage for binding to the F-pili on the
bacteria. The g3p-D3 interaction is not solely with either g3p-
D1 or g3p-D2, but it is indeed most pronounced with the
complex of these two domains, g3p-D12 (Fig. 3). Indeed,
the two N-terminal domains g3p-D1 and g3p-D2 have a spe-
ci¢c interface for each other, which leads to the formation of a
complex even in the absence of their covalent linkage [2].
3.3. Implications for selective infection of phage (SIP)
strategies
In these approaches, domains g3p-D12 (or just g3p-D1) are
expressed separately as a soluble protein and hence no longer
covalently linked to the phage coat. The phage coat itself
harbours only g3p-D3 and lacks the two N-terminal domains
g3p-D12 which, therefore, renders the phage non-infective.
Infectivity should only be restored by a cognate interaction
between a receptor fused to the N-terminus of g3p-D3 (and
thereby displayed on the phage surface) and a ligand fused to
the C-terminus of soluble g3p-D12 [6^8,17,18].
Our observation, that the speci¢c interaction between g3p-
D12 and g3p-D3 is capable of restoring the infectivity of
otherwise non-infective phage (Fig. 3), has implications for
the use of SIP strategies to identify cognate interactions be-
tween proteins. We therefore constructed a model system us-
ing GroEL minichaperone, hereafter referred to as GroEL*
Fig. 1. Schematic representation of the g3 protein in phages (fd)
and vectors (pUC). The presence of the domains g3p-D1 (residues
1^67), g3p-D2 (residues 82^217) and/or g3p-D3 (residues 257^406) is
indicated by boxes. The glycine-rich linkers between g3p-D1, g3p-
D2 and g3p-D3 and the C-terminal membrane anchor, respectively,
are indicated by lines. Coding regions for receptors, ligands and the
kanR gene are also indicated by boxes. Non-coding DNA regions
are indicated by broken lines.
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(residues 191^345 of the apical domain of GroEL [10]), as the
receptor and two putative peptide substrates, P1 and P2, as
ligands.
Increasing amounts of periplasmic extracts containing g3p-
D12-peptide fusions were incubated with non-infective phage
fd-GroEL*-D3 (Fig. 4A). The mixtures were subsequently
used to infect E. coli bearing the F-pilus. Although the infec-
tivity is drastically reduced (104 times lower) compared to that
of intact phage fd-D123 (Fig. 4B), extracts containing the g3p-
D12-P1 or g3p-D12-P2 fusion proteins increased the infectiv-
ity of fd-GroEL*-D3 in a concentration-dependent manner
(Fig. 4A). The infectivity in the presence of g3p-D12-P1 or
g3p-D12-P2 was increased up to about 100-fold compared to
phage fd-GroEL*-D3 alone, or when mixed with g3p-D12
and the non-cognate g3p-D12-P3 fusion (Fig. 4). These results
show that peptides P1 and P2 restore the infectivity of non-
infective phage fd-GroEL*-D3 in vitro when linked to the
C-terminus of g3p-D12. Peptides P1 and P2 are indeed cog-
nate substrates for GroEL*.
We subsequently examined the reconstitution of fd-
GroEL*-D3 infectivity directly in bacterial cultures (Fig.
4B). The selection in vivo, compartmentalised within individ-
ual host cells, takes place without prior harvesting of extruded
phage as a result of the interaction in the bacterial periplasm
between receptor-displaying phage and g3p-D12-ligand fu-
sions (an adaptation of [18] ; see Section 2.4). We observed
about 10 times more infection events (2^3U103 cfu) in bacte-
rial cultures where phage fd-GroEL*-D3 was expressed with
cognate peptide fusions (g3p-D12-P1 and g3p-D12-P2) than in
cultures where phage fd-GroEL*-D3 was expressed with the
non-cognate g3p-D12-P3 or g3p-D12 (1^3U102 cfu; Fig. 4B).
Under these conditions, we were able to select cognate ligand/
receptor pairs from cells producing phage fd-D12-P2/
GroEL*-D3 mixed with an excess of cells producing phage
fd-D12-P3/GroEL*-D3. The number of speci¢c phage encod-
ing the substrate peptide increased in a single round from
Fig. 2. Phage-binding to g3p-D12. A: Interaction of phages fd-
D123, fd-D13, fd-D23 or fd-D3 with immobilised g3p-D12 in ELI-
SA. B: E¡ect of polypeptide fusions to phage fd-D3 on the interac-
tion with immobilised g3p-D12 in ELISA.
Fig. 3. In vitro restoration of fd-D3 infectivity with g3p-D12. Dif-
ferent amounts of puri¢ed g3p-D12 protein were incubated with
phage fd-D3, which was subsequently used to infect E. coli cells.
Fig. 4. Reconstitution of fd-GroEL*-D3 infectivity. A: In vitro re-
constitution. Puri¢ed phage fd-GroEL*-D3 was incubated with seri-
al dilutions of periplasmic extracts containing g3p-D12-P1 (a), g3p-
D12-P2 (b), g3p-D12-P3 (E) or g3p-D12 (F). B: In vivo reconstitu-
tion. Donor E. coli cells producing phage fd-GroEL*-D3 and ex-
pressing di¡erent or no g3p-D12 fusions were mixed with acceptor
cells and resulting infective events were determined. The x-axis la-
bels denote the soluble and phage coat incorporated g3p fusions ex-
pressed by the various donor strains. For comparison, the number
of infective events observed using fd-TET cells (donor strain pro-
ducing phage displaying g3p-D123) is shown. The di¡erence in in-
fectivity between cognate (P1, P2) and non-cognate (P3) pairs of
g3p-D12 fusions and fd-GroEL*-D3 in vitro (A) is bigger than that
seen in vivo (B). This is due to a higher recovery of infectivity of
fd-GroEL*-D3 when mixed with g3p-D12-P3 (or indeed naked g3p-
D12) under the in vivo regime and represents a signi¢cant level of
background infectivity especially under these conditions.
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1/103 to 7/30 or from 1/104 to 1/30; a 200^300-fold enrichment
for the cognate peptide P2/GroEL* pair was achieved in a
single round of selection.
These results indicate that despite a speci¢c interaction be-
tween g3p-D12 and g3p-D3, SIP strategies can provide an
assay for cognate interactions.
3.4. Implications for phage infectivity
It is interesting to speculate on the biological function of
the interactions we have detected. In the past, g3p-D3 was
regarded as an independent domain within g3p, which proved
su⁄cient to cap phage during extrusion [3,19] and led to the
formation of temperature and detergent-resistant phage par-
ticles [20,21]. This view is supported by the observation that
g3p-D12 can be shaved o¡ the phage particle through subti-
lisin cleavage in the glycine-rich linker between g3p-D2 and
g3p-D3 [3,19]. By contrast, the N-terminal domains g3p-D1
and D2 were found to interact with each other to form a
stable complex [2,22,23]; indeed, the interaction of the g3p-
D2 domain with g3p-D1 leads to an increase in its thermal
stability (Tmg3pÿD2 = 45‡C; Tmg3pÿD12 = 57‡C) [22].
Our results described indicate that there are also signi¢cant
interactions between the g3p-D12 complex and g3p-D3. The
interdomain interactions within g3p should together lead to a
compact, stable organisation of the intact g3p on the tip of
the phage. Such an organisation may have the advantage of
protecting g3p from bacterial proteases, which should be less
able to degrade a condensed than an elongated, less stable
form of g3p.
During infection, the compact organisation of the intact
g3p would be expected to unravel. The glycine-rich linkers
may provide the conformational lability of the g3p-D123
complex and the optimal distance between domains required
during infection [2,22,23]. The binding of g3p-D2 to the bac-
terial F-pilus is known to break the interaction between g3p-
D1 and g3p-D2, freeing g3p-D1 for binding to its receptor
TolA [2,24]. We would also expect these events to disrupt
the interaction with g3p-D3. The three g3p domains would
then be arranged as ‘beads-on-string’ enabling g3p-D3 to
reach the bacterial inner membrane, where it is proposed to
form an entry port for the phage DNA [25].
The covalent link between the three domains seems to be
required for the infection process, as in its absence, like in
case of the SIP strategies, phage infectivity is reduced 104^
106-fold. It is possible that binding of the individual g3p do-
mains to di¡erent loci during infection induces signi¢cant
forces on g3p, which non-covalent links do not survive. In-
deed in the intact chain, multiple receptor-binding may cause
a force-induced conformational change, which could aid the
partitioning of g3p-D3 into the inner membrane.
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